ARF Induces Autophagy by Virtue of Interaction with Bcl-xl*

  1. Maureen E. Murphy,2
  1. Division of Medical Sciences, the §Smolensk State Medical Academy Graduate Program, and the Division of Basic Sciences, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 and Zilfou Therapeutics, Inc., Allentown, Pennsylvania 18104
  1. 2 To whom correspondence should be addressed: Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. Fax: 215-728-4333; E-mail: Maureen.Murphy{at}FCCC.edu.

Abstract

The ARF tumor suppressor controls a well-described p53/Mdm2-dependent oncogenic stress checkpoint. In addition, ARF has recently been shown to localize to mitochondria, and to induce autophagy; however, this has never before been demonstrated for endogenous ARF, and the molecular basis for this activity of ARF has not been elucidated. Using an unbiased mass spectrometry-based approach, we show that mitochondrial ARF interacts with the Bcl2 family member Bcl-xl, which normally protects cells from autophagy by inhibiting the Beclin-1/Vps34 complex, which is essential for autophagy. We find that increased expression of ARF decreases Beclin-1/Bcl-xl complexes in cells, thereby providing a basis for ARF-induced autophagy. Our data also indicate that silencing p53 leads to high levels of ARF and increased autophagy, thereby providing a possible basis for the finding by others that p53 inhibits autophagy. The combined data support the premise that ARF induces autophagy in a p53-independent manner in part by virtue of its interaction with Bcl-xl.

Footnotes

  • * This work was supported, in whole or in part, by National Institutes of Health R01 CA080854 (to M. M.) and R01 CA150002 (to M. M.). This work was also supported by the Philippe Foundation (to O. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Graphic The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.

  • 1 These authors contributed equally to this work.

  • Received June 19, 2008.
  • Revision received November 25, 2008.
Table of Contents

Submit your work to JBC.

You'll be in good company.